Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2023 - Issue 2

Association between Migraine and Attention Deficit Hyperactivity Disorder: Systematic Review Download PDF


, , , , , , , , , ,
Abstract

It has long been believed that primary headaches and attention-deficit/hyperactivity disorder (ADHD) are related. In addition, it is believed that stimulants, the most successful treatment for ADHD, frequently cause headaches as a side effect. PubMed, Web of Science, Science Direct, EBSCO, SCOPUS, Wiley, and the Cochrane Library were the search engines that were utilised. Before performing a full-text analysis, study articles were first evaluated using Rayyan QCRI's title and abstract criteria. This analysis includes 12 studies with 209130 ADHD patients in total. The reported studies documented an age range from 5 to 52 years old. Diagnoses of headaches, particularly migraines, were much more common in children with ADHD. In this systematic review, we comprehensively reviewed the available literature on the association between migraine and Attention Deficit Hyperactivity Disorder. Our findings suggested the presence of an association between migraine and ADHD. Higher migraine incidence rates were demonstrated among the pediatric population with ADHD.

Cite this article
Vancouver
Soltan MH, Albalawi RA, Alnawmasi NSM, Alshammari WFD, AlOmari LH, Ibrahim MIFB, et al. Association between Migraine and Attention Deficit Hyperactivity Disorder: Systematic Review. Pharmacophore. 2023;14(2):58-64. https://doi.org/10.51847/wSrSsrseWK
APA
Soltan, M. H., Albalawi, R. A., Alnawmasi, N. S. M., Alshammari, W. F. D., AlOmari, L. H., Ibrahim, M. I. F. B., Alshammari, S. H. M., Al Makir, M. K. A., Albalawi, W. M. B., Sabir, S. A. H. A., et al. (2023). Association between Migraine and Attention Deficit Hyperactivity Disorder: Systematic Review. Pharmacophore, 14(2), 58-64. https://doi.org/10.51847/wSrSsrseWK

QR code:

Short Link:
Views: 985

Downloads: 155
Quick Access

Pharmacophore
ISSN: 2229-5402

Copyright © 2024 Pharmacophore, All rights are reserved and for all open access contents, the Creative Commons licensing terms apply.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.